EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation

Ricardo J Mack iD, Natasha M Flores, Geoffrey C Fox iD, Hanyang Dong, Metehan Cebeci, Simone Hausmann, Tourkian Chasan iD, Jill M Dowen, Brian D Strahl iD, Pawel K Mazur, Or Gozani iD

eLife · 2025

DOI: 10.7554/elife.107451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Ricardo J Mack und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Stanford University, Stanford, United States. Hauptthemen laut MEDLINE: Histones, Lung Neoplasms, Histone-Lysine N-Methyltransferase, Carcinogenesis. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, CPRIT Scholar in Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone H3 trimethylation at lysine 36 (H3K36me3) is a key chromatin modification that regulates fundamental physiological and pathological processes. In humans, SETD2 is the only known enzyme that catalyzes H3K36me3 in somatic cells and is implicated in tumor suppression across multiple cancer types. While there is considerable crosstalk between the SETD2-H3K36me3 axis and other epigenetic modifications, much remains to be understood. Here, we show that Setd2 functions as a potent tumor suppressor in a KRAS G12C -driven lung adenocarcinoma (LUAD) mouse model, and that acetylation enhances SETD2 in vitro methylation of H3K36 on nucleosome substrates. In vivo, Setd2 ablation accelerates lethality in an autochthonous KRAS G12C -driven LUAD mouse tumor model. Biochemical analyses reveal that polyacetylation of histone tails in a nucleosome context promotes H3K36 methylation by SETD2. In addition, monoacetylation exerts position-specific effects to stimulate SETD2 methylation activity. In contrast, mono-ubiquitination at various histone sites, including at H2AK119 and H2BK120, does not affect SETD2 methylation of nucleosomes. Together, these findings provide insight into how SETD2 integrates histone modification signals to regulate H3K36 methylation and highlights the potential role of SETD2-associated epigenetic crosstalk in cancer pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesLung NeoplasmsHistone-Lysine N-MethyltransferaseCarcinogenesisProto-Oncogene Proteins p21(ras)Adenocarcinoma of LungAnimalsAcetylationMiceHumansMethylationDisease Models, AnimalNucleosomes

Stichwörter der Autor:innen

KRASNSD2SETD2cancer biologyepigenetichistone methylationhumanlung cancer

Substanzen

HistonesHistone-Lysine N-MethyltransferaseSETD2 protein, mouseHras protein, mouseProto-Oncogene Proteins p21(ras)SETD2 protein, humanNucleosomes

Autor:innen und Institutionen

  • Department of Biology, Stanford University, Stanford, United States.
  • Cancer Biology Training Program, Stanford University, School of Medicine, Stanford, United States.
  • Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
  • Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, United States.
  • Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, United States.
  • Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, United States.

ORCID-Profile: Ricardo J Mack, Geoffrey C Fox, Tourkian Chasan, Brian D Strahl, Or Gozani

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • CPRIT Scholar in Cancer Research
  • DOD Peer Reviewed Cancer Research Program
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Mack, R. J., Flores, N. M., Fox, G. C., Dong, H., Cebeci, M., Hausmann, S., Chasan, T., Dowen, J. M., Strahl, B. D., Mazur, P. K., & Gozani, O. (2025). SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation. eLife. https://doi.org/10.7554/elife.107451

Vancouver

Mack RJ, Flores NM, Fox GC, Dong H, Cebeci M, Hausmann S, et al. SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation. eLife. 2025. doi:10.7554/elife.107451

BibTeX
@article{Mack2025,
  author = {Mack, Ricardo J and Flores, Natasha M and Fox, Geoffrey C and Dong, Hanyang and Cebeci, Metehan and Hausmann, Simone and Chasan, Tourkian and Dowen, Jill M and Strahl, Brian D and Mazur, Pawel K and Gozani, Or},
  title = {SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.107451}
}
Kostenlos starten →